Bal Pharma Q2 Results FY27: Profit Nearly Doubles, Revenue Rs 89.95 Cr, PAT Rs 1.43 Cr

Bal Pharma Ltd (BALPHARMA) Q2 Results FY27 announced on 11 November 2026, covering the company's financial performance for the July to September quarter. The results date brought Bal Pharma Q2 Results FY27 to readers with consolidated revenue of Rs 89.95 Cr and net profit (PAT) of Rs 1.43 Cr, both higher YoY. Consolidated results are the basis for every figure in this article.

This Univest analysis of Bal Pharma Q2 Results moves from the headline numbers to the drivers behind them. The results analysis covers the financial highlights, business factors, outlook and risks, and begins with the table of headline figures that follows.

Click Here – Get Free Investment Predictions

Bal Pharma Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 89.95 Cr	Rs 74.02 Cr	+21.52% YoY
Operating Profit	Rs 8.66 Cr	Rs 5.73 Cr	+51.13% YoY
Net Profit (PAT)	Rs 1.43 Cr	Rs 0.72 Cr	+98.61% YoY

Source: company filing for Bal Pharma Q2 Results FY27, 11 November 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Bal Pharma Q2 Results: What Stands Out

• Revenue: consolidated revenue rose to Rs 89.95 Cr from Rs 74.02 Cr, an increase of 21.52% over the same quarter last year.
• Net profit: Bal Pharma Q2 Results FY27 show PAT of Rs 1.43 Cr against Rs 0.72 Cr, which is 98.61% higher on a YoY basis.
• Operating Profit: the line moved to Rs 8.66 Cr from Rs 5.73 Cr, a YoY growth of 51.13% for the quarter.
• Risk headline: return on equity of 7.92% and debt of 1.94 times total assets in FY26 are the main watch points.
• Next step: the performance analysis below sets the revenue, Operating Profit and net profit moves side by side.

Bal Pharma Q2 Results FY27: Performance Analysis

Bal Pharma Q2 Results FY27 show consolidated revenue of Rs 89.95 Cr for July to September 2026, up 21.52% YoY from Rs 74.02 Cr. Net profit rose 98.61% to Rs 1.43 Cr from Rs 0.72 Cr, while Operating Profit grew 51.13% to Rs 8.66 Cr from Rs 5.73 Cr.

In the results analysis, revenue growth of 21.52% and Operating Profit growth of 51.13% sit beside a net profit increase of 98.61%, the largest of the three YoY moves. Bal Pharma Q2 Results FY27 therefore show both profit lines rising faster than revenue on an annual comparison, a pattern that follows directly from the supplied figures.

Investors following Bal Pharma Q2 Results can compare later quarterly results with the Rs 74.02 Cr revenue, Rs 5.73 Cr Operating Profit and Rs 0.72 Cr net profit of the base quarter. That comparison is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to revenue as the first business factor, with consolidated revenue rising 21.52% YoY to Rs 89.95 Cr from Rs 74.02 Cr. Bal Pharma Q2 Results FY27 therefore begin from a larger sales base than a year earlier.

Net Profit Growth – Net profit rose 98.61% YoY to Rs 1.43 Cr from Rs 0.72 Cr, nearly doubling over the same quarter last year. This is the largest percentage move among the three reported lines in the quarterly results.

Operating Profit Growth – Operating Profit increased 51.13% YoY to Rs 8.66 Cr from Rs 5.73 Cr, growing faster than revenue at 21.52%. These three factors set up the FY27 outlook that follows.

FY27 Outlook After Bal Pharma Q2 Results

The FY27 outlook after Bal Pharma Q2 Results depends on the quarters still to be reported, because one quarter does not decide the full year. Full-year FY27 figures will build on the Rs 89.95 Cr of revenue and Rs 1.43 Cr of net profit reported for July to September 2026.

This results analysis rests on the disclosed numbers alone, and each later filing can be compared against them, for example on the Univest Screener. Alongside that base, the risks after Bal Pharma Q2 Results FY27 deserve equal attention.

Key Risks to Watch After Bal Pharma Q2 Results FY27

Low Return on Equity

Return on equity was low at 7.92% in FY26. After Bal Pharma Q2 Results FY27, the YoY growth in net profit starts from a base of Rs 0.72 Cr, so returns on shareholders' capital remain a point to track in later filings.

High Debt Level

Debt is high at 1.94 times total assets in FY26. This debt level is a supplied risk marker that investors can watch alongside the Rs 8.66 Cr Operating Profit reported for the quarter.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 0.72 Cr to Rs 3.59 Cr over the last 5 quarters. The Rs 1.43 Cr reported for July to September 2026 sits within that range, which frames the conclusion.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Bal Pharma Q2 Results FY27 show consolidated results with revenue of Rs 89.95 Cr, Operating Profit of Rs 8.66 Cr and net profit of Rs 1.43 Cr, all higher YoY. The quarterly results give readers a factual base, and Bal Pharma Q2 Results are best read with the risks in view. Investors using the Univest app should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Bal Pharma Q2 Results FY27

What are Bal Pharma Q2 Results FY27?

Ans. Bal Pharma Q2 Results FY27 are the consolidated quarterly results for July to September 2026, showing revenue of Rs 89.95 Cr. Alongside this, net profit came in at Rs 1.43 Cr, as the Quick Answer summarises.

What is the results date for Bal Pharma Q2 Results FY27?

Ans. Bal Pharma declared the results date as 11 November 2026 for the July to September quarter, which means the filing falls in the Q2 FY27 cycle. The introduction above covers the results date and the consolidated basis.

What revenue was reported in Bal Pharma Q2 Results FY27?

Ans. Bal Pharma Q2 Results FY27 report revenue of Rs 89.95 Cr, compared with Rs 74.02 Cr a year earlier, so revenue rose 21.52% YoY. The Financial Highlights table lists both figures side by side.

What net profit was reported in Bal Pharma Q2 Results FY27?

Ans. Bal Pharma reported net profit of Rs 1.43 Cr in Bal Pharma Q2 Results FY27, compared with Rs 0.72 Cr a year earlier, which means net profit rose 98.61% YoY, as the Key Takeaways section notes.

How much YoY growth did revenue show in Bal Pharma Q2 Results FY27?

Ans. Revenue showed YoY growth of 21.52% in Bal Pharma Q2 Results FY27, moving from Rs 74.02 Cr to Rs 89.95 Cr, while the Performance Analysis section explains how this sits beside the profit lines.

Did net profit rise or fall in Bal Pharma Q2 Results?

Ans. Net profit rose in Bal Pharma Q2 Results, reaching Rs 1.43 Cr against Rs 0.72 Cr a year earlier, an increase of 98.61%, which is the largest percentage move among the reported lines in the Performance Analysis.

What was the Operating Profit in Bal Pharma Q2 Results FY27?

Ans. Bal Pharma Q2 Results FY27 show Operating Profit of Rs 8.66 Cr against Rs 5.73 Cr a year earlier, so Operating Profit grew 51.13% YoY, as the Key Business Factors section details.

Are Bal Pharma Q2 Results consolidated results or standalone results?

Ans. Bal Pharma Q2 Results are consolidated results, so every figure in this article uses the consolidated basis. This is stated in the introduction and again in the Conclusion, where the consolidated results are summarised.

What business factors shaped Bal Pharma Q2 Results FY27?

Ans. The disclosed business factors in Bal Pharma Q2 Results FY27 are revenue growth of 21.52% YoY, net profit growth of 98.61% and Operating Profit growth of 51.13%, which the Key Business Factors section explains.

What are the key risks after Bal Pharma Q2 Results FY27?

Ans. The supplied risks after Bal Pharma Q2 Results FY27 are return on equity of 7.92% in FY26, debt at 1.94 times total assets and volatile quarterly net profit, all set out in the Key Risks section.

What is the outlook after Bal Pharma Q2 Results?

Ans. The FY27 outlook after Bal Pharma Q2 Results depends on the quarters still to be reported, while the Outlook section compares future filings with the Rs 89.95 Cr revenue base reported for this quarter.

Where can I find the complete Bal Pharma Q2 Results FY27 data?

Ans. The complete Bal Pharma Q2 Results FY27 data sits in the Financial Highlights table above, while the Univest Screener lets readers review the same consolidated results and the results date alongside other listed companies.